These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 23307543)
21. A description of the clinical course of severe benzonatate poisonings reported in the literature and to NPDS: A systematic review supplemented with NPDS cases. Minhaj FS; Leonard JB Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S39-S48. PubMed ID: 34219543 [TBL] [Abstract][Full Text] [Related]
22. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports. Okon E; Engell C; van Manen R; Brown J Pharmacotherapy; 2013 Jan; 33(1):63-8. PubMed ID: 23307547 [TBL] [Abstract][Full Text] [Related]
23. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Nourjah P; Ahmad SR; Karwoski C; Willy M Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):398-405. PubMed ID: 16294364 [TBL] [Abstract][Full Text] [Related]
24. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database. Roberto G; Piccinni C; D'Alessandro R; Poluzzi E Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799 [TBL] [Abstract][Full Text] [Related]
25. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy. Knudsen JF; Sokol GH; Flowers CM J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366 [TBL] [Abstract][Full Text] [Related]
26. Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants. Mosholder AD; Pamer CA J Child Adolesc Psychopharmacol; 2006; 16(1-2):33-6. PubMed ID: 16553527 [TBL] [Abstract][Full Text] [Related]
28. Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). Alsheikh-Ali AA; Karas RH Am J Cardiol; 2007 Feb; 99(3):379-81. PubMed ID: 17261402 [TBL] [Abstract][Full Text] [Related]
29. The FDA drug safety surveillance program: adverse event reporting trends. Weiss-Smith S; Deshpande G; Chung S; Gogolak V Arch Intern Med; 2011 Mar; 171(6):591-3. PubMed ID: 21444854 [No Abstract] [Full Text] [Related]
30. Impact of a drug safety communication on the severity of benzonatate exposures reported to poison centers. Leonard JB; Seung H; Klein-Schwartz W Pharmacoepidemiol Drug Saf; 2021 Jan; 30(1):45-52. PubMed ID: 32964590 [TBL] [Abstract][Full Text] [Related]
32. Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration. Brajovic S; Piazza-Hepp T; Swartz L; Dal Pan G Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):565-70; discussion 571-2. PubMed ID: 22359404 [TBL] [Abstract][Full Text] [Related]
33. Overdoses and ingestions of second-generation antipsychotics in children and adolescents. Antia SX; Sholevar EH; Baron DA J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):970-85. PubMed ID: 16379518 [TBL] [Abstract][Full Text] [Related]
34. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS). Evoy KE; Covvey JR; Peckham AM; Ochs L; Hultgren KE Res Social Adm Pharm; 2019 Aug; 15(8):953-958. PubMed ID: 31303196 [TBL] [Abstract][Full Text] [Related]
35. The state of dietary supplement adverse event reporting in the United States. Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260 [TBL] [Abstract][Full Text] [Related]
36. The role of databases in drug postmarketing surveillance. Rodriguez EM; Staffa JA; Graham DJ Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586 [TBL] [Abstract][Full Text] [Related]
37. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Budnitz DS; Pollock DA; Mendelsohn AB; Weidenbach KN; McDonald AK; Annest JL Ann Emerg Med; 2005 Feb; 45(2):197-206. PubMed ID: 15671977 [TBL] [Abstract][Full Text] [Related]
38. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Wysowski DK; Swartz L Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284 [TBL] [Abstract][Full Text] [Related]
39. Epidemiology of emergency department visits for opioid overdose: a population-based study. Hasegawa K; Brown DF; Tsugawa Y; Camargo CA Mayo Clin Proc; 2014 Apr; 89(4):462-71. PubMed ID: 24629443 [TBL] [Abstract][Full Text] [Related]
40. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project. de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC; PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]